Automated insulin delivery: Benefits outweigh risk to eyes

+Practice
In print
Research: Diabetes

Automated insulin delivery: Benefits outweigh risk to eyes

By Francesc March and Ben Wheeler
diabetes pump
Younger age at initiation of automated insulin delivery protects against worsening diabetic retinopathy [Image: Halfpoint on iStock]

Automated insulin delivery is a new technology used to control diabetes that could risk diabetic retinopathy deterioration. Research done in Dunedin has now demonstrated these systems are safe for the eyes

Key Points, Rapid glycaemic control has previously been associated with early worsening of diabetic retinopathy. New research has demonstrated stable or improve, Pract Green w Pale Yellow
References

Johansson MME, March de Ribot F, Sime MJ, et al. Short-term diabetic retinopathy status in people with type 1 diabetes commencing automated insulin delivery. Diabetes Technol Ther 2025: 10 February online.